The additional 3,500 square feet will allow the Altman Clinical and Translational Research Institute to accelerate medical research to improve human health.

La Jolla research is taking up more space, as the UC San Diego Altman Clinical and Translational Research Institute has added 3,500 square feet of new clinic space to its main facility.

The ACTRI L2 Center for Clinical Research will boost the institute’s ability to serve participants in groundbreaking clinical trials by more than 30 percent and has already welcomed its first study participant.

The expansion will aid ACTRI’s discoveries that lead to new treatments, ACTRI director, Dr David “Davey” Smith, said in a press release.

“The expanded space means more trials, faster answers and better access for our community to the therapies of tomorrow.”

ACTRI has facilitated clinical trials by providing research teams with shared clinical space, research coordinators, nursing staff and lab techs since 2016.

The new L2 Center for Clinical Research will support more than 300 clinical research studies on diseases and conditions such as Parkinson’s disease, Type 2 diabetes, chronic pain and bipolar disorder. New therapies being investigated include bacteriophage therapy to treat drug-resistant urinary tract infections, gene therapy for cardiomyopathy and implanted neurostimulation devices for migraines. 

The expansion will also allow ACTRI to deliver more innovative therapies to underserved communities.

© lajolla.ca